Literature DB >> 17409159

The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.

Zhilong Yang1, Charles Wood.   

Abstract

The replication and transcription activator (RTA) protein of Kaposi's sarcoma (KS)-associated herpesvirus (KSHV)/human herpesvirus 8 functions as the key regulator to induce KSHV lytic replication from latency through activation of the lytic cascade of KSHV. Elucidation of the host factors involved in RTA-mediated transcriptional activation is pivotal for understanding the transition between viral latency and lytic replication. KSHV-RTA binding protein (K-RBP) was previously isolated as a cellular RTA binding protein of unknown function. Sequence analysis showed that K-RBP contains a Kruppel-associated box (KRAB) at the N terminus and 12 adjacent zinc finger motifs. In similarity to other KRAB-containing zinc finger proteins, K-RBP is a transcriptional repressor. Mutational analysis revealed that the KRAB domain is responsible for the transcriptional suppression activity of this protein and that the repression is histone deacetylase independent. K-RBP was found to repress RTA-mediated transactivation and interact with TIF1beta (transcription intermediary factor 1beta), a common corepressor of KRAB-containing protein, to synergize with K-RBP in repression. Overexpression and knockdown experiment results suggest that K-RBP is a suppressor of RTA-mediated KSHV reactivation. Our findings suggest that the KRAB-containing zinc finger protein K-RBP can suppress RTA-mediated transactivation and KSHV lytic replication and that KSHV utilizes this protein as a regulator to maintain a balance between latency and lytic replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409159      PMCID: PMC1900108          DOI: 10.1128/JVI.02648-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  88 in total

1.  Characterization of a novel KRAB/C2H2 zinc finger transcription factor involved in bone development.

Authors:  A H Jheon; B Ganss; S Cheifetz; J Sodek
Journal:  J Biol Chem       Date:  2001-02-20       Impact factor: 5.157

2.  Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD.

Authors:  D C Schultz; J R Friedman; F J Rauscher
Journal:  Genes Dev       Date:  2001-02-15       Impact factor: 11.361

3.  Molecular cloning and characterization of a KRAB-containing zinc finger protein, ZNF317, and its isoforms.

Authors:  H Takashima; H Nishio; H Wakao; M Nishio; K Koizumi; A Oda; T Koike; K Sawada
Journal:  Biochem Biophys Res Commun       Date:  2001-11-09       Impact factor: 3.575

4.  Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus ORF50/Lyta gene expression.

Authors:  S Sakakibara; K Ueda; J Chen; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.

Authors:  D M Lukac; L Garibyan; J R Kirshner; D Palmeri; D Ganem
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.

Authors:  M J Song; H J Brown; T T Wu; R Sun
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Transcriptional repression mediated by the KRAB domain of the human C2H2 zinc finger protein Kox1/ZNF10 does not require histone deacetylation.

Authors:  P Lorenz; D Koczan; H J Thiesen
Journal:  Biol Chem       Date:  2001-04       Impact factor: 3.915

8.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence.

Authors:  S Wang; S Liu; M Wu; Y Geng; C Wood
Journal:  Arch Virol       Date:  2001-07       Impact factor: 2.574

9.  Characterization of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF57 promoter.

Authors:  W Duan; S Wang; S Liu; C Wood
Journal:  Arch Virol       Date:  2001       Impact factor: 2.574

10.  Association of ZNF74 gene genotypes with age-at-onset of schizophrenia.

Authors:  K Takase; T Ohtsuki; O Migita; M Toru; T Inada; K Yamakawa-Kobayashi; T Arinami
Journal:  Schizophr Res       Date:  2001-12-01       Impact factor: 4.939

View more
  25 in total

1.  Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.

Authors:  Zhilong Yang; Zhangcai Yan; Charles Wood
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

2.  Regulation of episomal gene expression by KRAB/KAP1-mediated histone modifications.

Authors:  Isabelle Barde; Elisa Laurenti; Sonia Verp; Anna Claire Groner; Christopher Towne; Viviane Padrun; Patrick Aebischer; Andreas Trumpp; Didier Trono
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

3.  Tpl2/AP-1 enhances murine gammaherpesvirus 68 lytic replication.

Authors:  Xudong Li; Jun Feng; Shijia Chen; Li Peng; Wei-Wu He; Jing Qi; Hongyu Deng; Ren Sun
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.

Authors:  Dhivya Ramalingam; Christine Happel; Joseph M Ziegelbauer
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

5.  Enhancement of autophagy during lytic replication by the Kaposi's sarcoma-associated herpesvirus replication and transcription activator.

Authors:  Hui-Ju Wen; Zhilong Yang; You Zhou; Charles Wood
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

6.  Downregulation of IRF4 induces lytic reactivation of KSHV in primary effusion lymphoma cells.

Authors:  Adriana Forero; Kevin D McCormick; Frank J Jenkins; Saumendra N Sarkar
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

7.  Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.

Authors:  Jiguo Chen; Fengchun Ye; Jianping Xie; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

8.  Minority stress and leukocyte gene expression in sexual minority men living with treated HIV infection.

Authors:  Annesa Flentje; Kord M Kober; Adam W Carrico; Torsten B Neilands; Elena Flowers; Nicholas C Heck; Bradley E Aouizerat
Journal:  Brain Behav Immun       Date:  2018-03-13       Impact factor: 7.217

9.  Using gene expression profiles from peripheral blood to identify asymptomatic responses to acute respiratory viral infections.

Authors:  Alexander Statnikov; Nikita I Lytkin; Lauren McVoy; Jörn-Hendrik Weitkamp; Constantin F Aliferis
Journal:  BMC Res Notes       Date:  2010-10-20

10.  Identification and characterization of a new Kaposi's sarcoma-associated herpesvirus replication and transcription activator (RTA)-responsive element involved in RTA-mediated transactivation.

Authors:  Hui-Ju Wen; Veenu Minhas; Charles Wood
Journal:  J Gen Virol       Date:  2009-02-17       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.